Background

Mr. Magnus Lundberg served as the President of Phadia AB (Formerly, Pharmacia Diagnostics AB), a division of Pharmacia Corporation from March 1999 to 2011 and served as its Chief Executive Officer. From September 1996 to March 1999, Mr. Lundberg served as the President of both Chiron Therapeutics and Chiron Vaccines, each a division of Chiron, a biotechnology company. From 1981 to September 1996, Mr. Lundberg held various management positions including, Executive President ... of Pharmacia Diagnostics AB, Uppsala and Vice President of Chiron Corporation, USA. He serves as the Chairman of ConvaTec Healthcare B S.a.r.l., Allergon AB, Airsonett AB and Uppsala Bio. Mr. Lundberg has been a Director of Onyx Pharmaceuticals, Inc. since June 2000. Mr. Lundberg serves as a Director of SwedenBIO Service AB, Uppsvenska Handelskammaren, ConvaTec Inc. and Sweden Biotechnology Industry Organization. He serves as Member of the Board of the Upswedish Chamber of Commerce. He serves as Board Member in companies such as Bioimmix and Allergon. He served as a Director of Aerocrine AB from 2002 to May 5, 2011. He served as Director of Biacore International AB from 2002 to April 2004. He holds an M.Sc. Degree in Biology and Biochemistry from Åbo Akademi in Turku, Finland.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.